Smart Charts | Add to my portfolio | Derivative
You need to upgrade your Flash Player
News |
||||||||||||||||||||||||||
| 30 Jan 12 | |
|---|---|
| 17:45 | Lupin gets USFDA nod for diabetes drug |
| 25 Jan 12 | |
| 00:59 | Lupin Q3 net up 4.95% at Rs 235.1 cr |
| 24 Jan 12 | |
| 15:06 | Lupin Q3 net up 4.95% at Rs 235 cr |
| 19 Jan 12 | |
| 00:53 | How Lupin cracked the Japanese pharma market |
| 04 Jan 12 | |
| 00:10 | Tricor to aid Lupin's earnings |
| 29 Dec 11 | |
| 19:56 | Lupin gets USFDA nod for generic cholesterol drug |
Stock Summary
Shareholding Pattern
|
| Promoters | 46.93 % |
| Mutual Funds / UTI | 7.07 % |
| FI/Bank | 0.04 % |
| Insurance | 10.13 % |
| Others | 0.00 % |
| Govt | 0.00 % |
| FII | 26.21 % |
| Non-Institutions | 9.63 % |
| Depository Receipts | 0.00 % |
| Total | 100.00 % |
Key Financials
| (Rs cr) | Dec 2011 | Dec 2010 | YOY |
|---|---|---|---|
| Operating Income | 1,818.93 | 1,510.21 | 20.44 |
| Total Expenses | 1,445.43 | 1,212.95 | 19.17 |
| Operating Profit | 373.50 | 297.26 | 25.65 |
| Other Income | 3.31 | 3.39 | -2.36 |
| PBDIT | 376.81 | 300.65 | 25.33 |
| PBT | 310.64 | 251.57 | 23.48 |
| Adjusted Net Profit | 235.06 | 224.03 | 4.92 |
Peer Group
|
| Company | Last (Rs) | Chg (%) | Mkt Cap (Rs cr) |
|---|---|---|---|
| Dr Reddy`s Labs | 1,670.50 | 2.16 | 28,322 |
| Cipla | 344.85 | 1.52 | 27,689 |
| Ranbaxy Labs. | 455.30 | -0.12 | 19,214 |
| Glaxosmit Pharma | 1,959.90 | -0.16 | 16,601 |
| Cadila Health. | 678.85 | 2.07 | 13,899 |
Funds Owning this Stock
| Scheme Name | Value (Rs cr) |
|---|---|
| Reliance Growth Fund - Inst (G) | 233.68 |
| Reliance Growth Fund - (G) | 233.68 |
| HDFC Top 200 Fund (G) | 150.68 |
| HDFC Equity Fund - (G) | 110.15 |
| SBI Magnum Tax Gain Scheme (G) | 95.83 |
Announcements |
Research Reports
|
| Date | Broker | Action | Price (Rs) | Report |
|---|---|---|---|---|
| 30/01 | Motilal Oswal | Buy | 460 | |
| 08/12 | Pinc Research | Accumulate | 451 | |
| 21/11 | Angel Broking | Buy | 455 | |
| 18/11 | Pinc Research | Buy | 447 | |
| 01/08 | Motilal Oswal | Buy | 449 |
Corporate Details
Registered Head Office
Address:159 C S T Road, Kalina Santacruz (East), Mumbai, MR-400098
|
Registrar's Details
Address:Lupin Ltd Investors Serv Dept 159 C S T Road Kalina Santa Cruz(E) Mumbai - 400 098 Ph: 91-22-66402323 Fax: N.A. |
Company Background
|
Sensex
| Company | Price | Gain (%) |
|---|---|---|
| NTPC | 176.30 | 2.71 |
| Hind. Unilever | 400.70 | 2.69 |
| Sun Pharma.Inds. | 556.25 | 2.38 |
| DLF | 230.30 | 1.97 |
| B H E L | 263.80 | 1.93 |


